SenesTech Reports Record Revenue and Growth in Q2 2025

SenesTech ( (SNES) ) has released its Q2 earnings. Here is a breakdown of the information SenesTech presented to its investors.

SenesTech, Inc., headquartered in Surprise, Arizona, is a pioneering company in the field of fertility control for managing animal pest populations, specifically known for its EPA-registered rodent birth control products. The company has positioned itself as a leader in providing sustainable and humane pest management solutions.

In its latest earnings report for the second quarter of 2025, SenesTech announced record revenue and gross profit margins, highlighting a 36% increase in revenues to $625,000 compared to the same period last year. The company’s Evolve™ rodent birth control products have shown significant growth, representing 83% of total revenue and achieving a 94% year-over-year sales increase.

Key financial metrics reveal a gross profit margin improvement to 65.4%, up from 54.2% in the previous year. Despite a net loss of $1.6 million, the company has managed to reduce its adjusted EBITDA loss to $1.4 million, showcasing progress towards profitability. SenesTech’s strategic initiatives include expanding its product line, enhancing e-commerce platforms, and increasing municipal deployments in major U.S. cities.

The company has also made strides in international markets, with pending regulatory approvals in Australia and New Zealand and a significant retail market adoption in rural America. SenesTech’s new manufacturing facility, equipped with automated capabilities, is set to meet the growing demand for its products, further improving capacity and gross margins.

Looking ahead, SenesTech remains focused on achieving sustainable growth and profitability. With a strong cash position and a diverse multi-channel distribution strategy, the company is well-positioned to continue its momentum in reshaping the rodenticide industry with its innovative, science-driven solutions.